Skip to main content

Day: February 25, 2021

Reliq Health Technologies, Inc. Announces Upcoming Shareholder Update Webinar

HAMILTON, Ontario, Feb. 25, 2021 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global telemedicine company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, wishes to inform shareholders that it will be hosting a webinar on March 2, 2021 at 6:00am PST / 9:00am EST to review the Company’s quarterly financial statements for Q2 Fiscal Year 2021 (October 1 – December 31, 2020), and provide a corporate update.Webinar Login Information:For those who are not able to attend the webinar, a recording will be available on the Company’s website (www.reliqhealth.com) immediately following the session.About Reliq HealthReliq Health Technologies is a rapidly growing global telemedicine company that develops innovative...

Continue reading

Kronos Bio Announces First Patient Dosed in Phase 1/2 Clinical Trial of KB-0742, an Oral CDK9 Inhibitor Targeting MYC-amplified Cancers

KB-0742 generated using the company’s proprietary small molecule microarray (SMM) screening platformInitial safety, pharmacokinetic and pharmacodynamic data expected in fourth quarter of 2021SAN MATEO, Calif. and CAMBRIDGE, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) — Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced that the first patient has been dosed in the Phase 1/2 clinical trial of KB-0742, a highly selective, orally bioavailable cyclin dependent kinase 9 (CDK9) inhibitor being developed to treat MYC-amplified solid tumors.“KB-0742 represents a promising new approach to treating cancers that are transcriptionally addicted to MYC. We are excited to have initiated our clinical development program for KB-0742, which emerged from our internal discovery research...

Continue reading

NaturalShrimp, Inc. Achieves Successful Inspection by the Texas Parks and Wildlife Department

Dallas, Texas, Feb. 25, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — NaturalShrimp, Inc. (OTCQB: SHMP), the aquaculture Company that has developed and patented the first commercially-operational RAS (Recirculating Aquaculture System), announced the recent inspection from the Texas Parks and Wildlife Department.An inspector from the Texas Parks and Wildlife Department visited the NaturalShrimp Facility recently in La Coste, Texas to perform a routine inspection of the facility and the shrimp. After viewing and inspecting the shrimp in various stocked tanks, the inspector submitted a final report saying that the shrimp had full guts and looked healthy. The inspection involved removing a sample of shrimp from the tanks and the inspector determined that none of the shrimp had issues with the following:·         Empty guts·        ...

Continue reading

NioBay Begins Trading on the OTCQB Venture Market in the U.S.

MONTREAL, Feb. 25, 2021 (GLOBE NEWSWIRE) — Niobay Metals Inc. (“NioBay” or the “Company”) (TSX-V: NBY; OTCQB: NBYCF) is pleased to announce that its common shares are now trading on the OTCQB Venture Market, a U.S. market operated by OTC Markets Group Inc. (“OTC”) in New York, under the symbol “NBYCF’’. NioBay will continue to trade on the TSX Venture Exchange under its symbol “NBY”.“NioBay’s OTCQB listing is an important step to provide easier access and trading capability in our Company’s shares for both institutional and retail investors,” stated Claude Dufresne, President and CEO of NioBay. “This provides NioBay with a platform to expand our U.S. shareholder profile and allow a broader group of investors to participate in the niobium market.”The OTC operates the world’s largest electronic interdealer quotation system for US...

Continue reading

NioBay Commence à Transiger sur le Marché OTCQB Venture Market aux États-Unis

MONTRÉAL, 25 févr. 2021 (GLOBE NEWSWIRE) — Les Métaux NioBay inc. (« NioBay » ou la « Société ») (TSX-V: NBY; OTCQB : NBYCF) a le plaisir d’annoncer que ses actions ordinaires se transigent maintenant sur le OTCQB Venture Market, un marché américain exploité par OTC Markets Group Inc. (« OTC ») à New York, sous le symbole « NBYCF ». NioBay continuera de se négocier à la Bourse de croissance TSX sous son symbole « NBY ».« L’inscription de NioBay à l’OTCQB est une étape importante pour faciliter l’accès et la capacité de négociation des actions de notre société aux investisseurs institutionnels et particuliers », a déclaré Claude Dufresne, président et chef de la direction de NioBay. « Cela fournit à NioBay une plate-forme pour élargir le profil de nos actionnaires américains et permettre à un groupe plus large d’investisseurs de...

Continue reading

HPQ Receives its First Mini-Generator Set Based on Clean Hydrogen Produced by Simply Combining Water and a Powder Bag

MONTREAL, Feb. 25, 2021 (GLOBE NEWSWIRE) — Innovative silicon solutions provider HPQ Silicon Resources Inc. (“HPQ” or the “Company”) (TSX-V: HPQ; FWB: UGE; Other OTC :HPQFF), is proud to announce that it has received the TREKHY® system, a portable hydrogen-based mini-power generator, jointly developed by the French companies Apollon Solar SAS (“Apollon”) and Pragma Industries SAS (“Pragma”). While continuing to work with Apollon on the development of new generations of more efficient silicon powders for hydrogen production, HPQ signed a Memorandum of Understanding with Apollon and Pragma to study the commercial potential of the TREKHY® autonomous power generator in Canada.The portable hydrogen-based power generator, a revolutionary productThe TREKHY® provides energy on demand. The system uses a compact fuel cell to provide electrical...

Continue reading

HPQ reçoit son premier mini-groupe électrogène à base d’hydrogène propre produit simplement en combinant de l’eau et un sachet de poudre

MONTRÉAL, 25 févr. 2021 (GLOBE NEWSWIRE) — Le fournisseur de solutions innovantes à base de silicium Ressources HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V : HPQ ; FWB : UGE ; Autre OTC : HPQFF), est heureux d’annoncer la réception du système TREKHY®, un mini-groupe électrogène portable à base d’hydrogène, développé conjointement par les sociétés françaises Apollon Solar SAS (« Apollon ») et Pragma Industries SAS (« Pragma »). Tout en continuant le travail avec Apollon sur le développement de nouvelles générations de poudres de silicium plus performantes pour la production d’hydrogène, HPQ a signé un protocole d’entente avec Apollon et Pragma dans le but d’étudier le potentiel commercial du générateur portable d’énergie TREKHY® au Canada.Le générateur portable d’énergie à base d’hydrogène, un produit révolutionnaireLe TREKHY®...

Continue reading

Clene Nanomedicine Presents Updated Interim Data from Phase 2 Multiple Sclerosis Programs at ACTRIMS Forum 2021

Blinded interim data from VISIONARY-MS continue to support the potential of CNM-Au8 to drive meaningful neurological functional improvements in MS patientsInterim REPAIR-MS results provide further evidence of CNM-Au8’s homeostatic effect on brain bioenergetics in MS patientsSALT LAKE CITY, Feb. 25, 2021 (GLOBE NEWSWIRE) — Clene Inc. (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) today announced that its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, will present blinded interim data from its VISIONARY-MS study and updated interim data from its REPAIR-MS study in on-demand presentations at the Americas Committee for Treatment and Research in Multiple Sclerosis (“ACTRIMS”) ACTRIMS Forum 2021 taking place virtually from February 25-27, 2021. Together, these complementary Phase 2...

Continue reading

Plus Products Inc. Announces Debentureholder Approval of Debenture Amendments

SAN MATEO, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) — Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (the “Company” or “PLUS”), a cannabis and hemp branded products company in the U.S., is pleased to announce today that, further to its press release dated February 3, 2021, holders (the “Debentureholders”) of the Company’s 8.00% unsecured convertible debentures due February 28, 2021 (the “Debentures”) have approved by way of signed instruments in writing in the form of the Form of Proxy, certain proposed amendments to the terms of the Debentures (the “Debenture Amendments”) and proposed resolutions for consideration (the “Resolution Amendments” and together with the Debenture Amendments, the “Amendments”). The Amendments have therefore been validly approved.As a result of such approval, the extraordinary meeting of Debentureholders...

Continue reading

DraftKings Welcomes Cal Ripken Jr. as Special Advisor to the Board of Directors

BOSTON, Feb. 25, 2021 (GLOBE NEWSWIRE) — Today, DraftKings (Nasdaq: DKNG) announced the appointment of baseball legend and entrepreneur Cal Ripken Jr. as a special advisor to the board of directors. Ripken will lend strategic insights to the board of directors and Chief Executive Officer on key company initiatives and will become a DraftKings equity holder.Ripken enjoyed a Hall of Fame Major League Baseball career and is one of only ten players in history with more than 3,000 hits and 400 home runs. He has won a World Series championship, two AL MVP Awards, two AL All-Star Game MVP Awards, two Gold Gloves, made 19 All-Star Game appearances and captured eight Silver Slugger Awards. However, he is most well known for his incredible streak of 2,632 consecutive games played which made him baseball’s all-time “Iron Man.” Since retiring...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.